These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25930117)

  • 61. Formulation and production of a blood-free and chemically defined virus production media for VERO cells.
    Alfano R; Pennybaker A; Halfmann P; Huang CY
    Biotechnol Bioeng; 2020 Nov; 117(11):3277-3285. PubMed ID: 32648943
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Metabolic active-high density VERO cell cultures on microcarriers following apoptosis prevention by galactose/glutamine feeding.
    Mendonça RZ; Arrózio SJ; Antoniazzi MM; Ferreira JM; Pereira CA
    J Biotechnol; 2002 Jul; 97(1):13-22. PubMed ID: 12052679
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
    Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
    Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.
    Genzel Y; Vogel T; Buck J; Behrendt I; Ramirez DV; Schiedner G; Jordan I; Reichl U
    Vaccine; 2014 May; 32(24):2770-81. PubMed ID: 24583003
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Studies on the efficiency of measles virus antigen production using VERO cell culture in a microcarrier system.
    Mendonça RZ; Vaz-de-Lima LR; Oliveira MI; Pereira CA; Hoshino-Shimizu S
    Braz J Med Biol Res; 1994 Jul; 27(7):1575-87. PubMed ID: 7874024
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
    Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
    Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.
    Albarnaz JD; De Oliveira LC; Torres AA; Palhares RM; Casteluber MC; Rodrigues CM; Cardozo PL; De Souza AM; Pacca CC; Ferreira PC; Kroon EG; Nogueira ML; Bonjardim CA
    Antiviral Res; 2014 Nov; 111():82-92. PubMed ID: 25241249
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
    George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
    Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A cell-detaching reactor for inoculation of anchorage-dependent CHO and Vero cells between stepwise-expanded bioreactors.
    Sun X; Zhang Y
    Biotechnol Lett; 2007 May; 29(5):697-701. PubMed ID: 17216536
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Partial inhibition of yellow fever virus replication in vitro with different phosphorothioate oligodeoxyribonucleotides.
    Tolou H; Puggelli H; Tock F; Durand JP
    Acta Virol; 1996 Apr; 40(2):73-9. PubMed ID: 8886115
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Application of Ambr15 system for simulation of entire SARS-CoV-2 vaccine production process involving macrocarriers.
    Jayson A; Goldvaser M; Dor E; Monash A; Levin L; Cherry L; Lupu E; Natan N; Girshengorn M; Epstein E; Rosen O
    Biotechnol Prog; 2022 Sep; 38(5):e3277. PubMed ID: 35633106
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Production of canine adenovirus type 2 in serum-free suspension cultures of MDCK cells.
    Castro R; Fernandes P; Laske T; Sousa MF; Genzel Y; Scharfenberg K; Alves PM; Coroadinha AS
    Appl Microbiol Biotechnol; 2015 Sep; 99(17):7059-68. PubMed ID: 25994255
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum-free production of rVSV-ZEBOV in Vero cells: Microcarrier bioreactor versus scale-X™ hydro fixed-bed.
    Kiesslich S; Vila-Chã Losa JP; Gélinas JF; Kamen AA
    J Biotechnol; 2020 Feb; 310():32-39. PubMed ID: 32006630
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor.
    Lohr V; Genzel Y; Behrendt I; Scharfenberg K; Reichl U
    Vaccine; 2010 Aug; 28(38):6256-64. PubMed ID: 20638458
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The use of tapioca as coverage in viral titration].
    Post PR; de Carvalho R; Brito EC; Galler R
    An Acad Bras Cienc; 1992; 64(1):79-86. PubMed ID: 1492720
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficient suspension bioreactor expansion of murine embryonic stem cells on microcarriers in serum-free medium.
    Alfred R; Radford J; Fan J; Boon K; Krawetz R; Rancourt D; Kallos MS
    Biotechnol Prog; 2011; 27(3):811-23. PubMed ID: 21538971
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Suspended aggregates as an immobilization mode for high-density perfusion culture of HEK 293 cells in a stirred tank bioreactor.
    Liu XM; Liu H; Wu BC; Li SC; Ye LL; Wang QW; Huang PT; Chen ZL
    Appl Microbiol Biotechnol; 2006 Oct; 72(6):1144-51. PubMed ID: 16568312
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High cell density cultivation of recombinant yeasts and bacteria under non-pressurized and pressurized conditions in stirred tank bioreactors.
    Knoll A; Bartsch S; Husemann B; Engel P; Schroer K; Ribeiro B; Stöckmann C; Seletzky J; Büchs J
    J Biotechnol; 2007 Oct; 132(2):167-79. PubMed ID: 17681630
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Production of recombinant proteins by vaccinia virus in a microcarrier based mammalian cell perfusion bioreactor.
    Bleckwenn NA; Golding H; Bentley WE; Shiloach J
    Biotechnol Bioeng; 2005 Jun; 90(6):663-74. PubMed ID: 15858791
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Screening different host cell lines for the dynamic production of measles virus.
    Grein TA; Schwebel F; Kress M; Loewe D; Dieken H; Salzig D; Weidner T; Czermak P
    Biotechnol Prog; 2017 Jul; 33(4):989-997. PubMed ID: 28054473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.